Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.

合并肝慢性丙肝（CHC）患者接受α干扰素包派罗欣治疗时存在肝功能失死亡风险。